Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Neurolinguistics Historical and Theoretical Perspectives by

bigCover of the book Globalization and Summit Reform by

bigCover of the book Handbook of Osteopathic Technique by

bigCover of the book Defining Prevention Science by

bigCover of the book Biology, History, and Natural Philosophy by

bigCover of the book Computers and Networks in the Age of Globalization by

bigCover of the book Genetic Information by

bigCover of the book Petrology of Lamproites by

bigCover of the book Metal Metabolism in Aquatic Environments by

bigCover of the book Coronary Vasculature by

bigCover of the book Contemporary Internal Medicine by

bigCover of the book The Commercialization of Genetic Research by

bigCover of the book How to Write a Successful Research Grant Application by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy